Graphene Oxide–Cationic Silver Nanocomposites Against AMR and MDR Pathogens
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing antimicrobial agents are ineffective against antimicrobial resistant (AMR) and multidrug resistant (MDR) pathogens, and there is a lack of broad-spectrum antimicrobial compositions to effectively treat and prevent microbial infections.
Innovation Solution
Graphene-silver nanocomposites comprising graphene oxide (GO) with cationic silver (Ag+) moieties bound to GO, forming a stable complex that synergistically enhances antimicrobial efficacy against a wide range of pathogens, including AMR and MDR strains.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antimicrobial agents are used, then treatment is provided for common infections, but effectiveness decreases against antimicrobial resistant (AMR) and multidrug resistant (MDR) pathogens
Solution Approach 1:
The patent combines graphene oxide with silver cations to create a nanocomposite material that exhibits broad-spectrum antimicrobial activity. This composite structure leverages the synergistic properties of both components: graphene oxide provides structural stability and surface area for silver binding, while silver cations contribute potent antimicrobial activity against AMR and MDR pathogens, including ESKAPE pathogens. The composite material achieves effective MIC values against resistant strains that conventional single agents cannot reach.
2Ease of operation
If broad-spectrum antimicrobial agents are used to treat unknown infections, then empiric treatment is provided, but antimicrobial resistance develops over time
Solution Approach 1:
The graphene oxide-silver cation nanocomposite exhibits intrinsic antimicrobial activity through its molecular structure and surface properties. The material automatically interacts with microbial cell membranes and intracellular components without requiring external intervention or adaptation. The graphene oxide framework continuously presents silver cations for antimicrobial action, maintaining effective MIC values against resistant pathogens over time without developing resistance mechanisms themselves.
3Reliability
If traditional antimicrobial compositions are used, then treatment is provided, but toxicity and side effects occur
Solution Approach 1:
The nanocomposite material exhibits selective antimicrobial activity through its interaction with microbial cell structures while maintaining compatibility with host tissues. The graphene oxide-silver cation complex specifically targets microbial cell membranes and intracellular processes, achieving effective MIC values against AMR and MDR pathogens. The localized action at the nanoscale reduces systemic toxicity and harmful effects compared to conventional bulk antimicrobial agents.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The GO-Ag+ nanocomposites exhibit potent antibacterial, antifungal, and antiviral effects at low concentrations, providing broad-spectrum antimicrobial activity with minimal toxicity, suitable for treating and preventing infections, including respiratory infections, and can be delivered via aerosol inhalation.
Implementation Method 1
graphene oxide (GO) with cationic silver (Ag+) moieties respectively bound to the GO
Implementation Method 2
cationic silver (Ag+) moieties bound to the GO
Implementation Method 3
The GO-Ag+ nanocomposites exhibit potent antibacterial, antifungal, and antiviral effects
Data Source
AI summary
The present invention relates to antimicrobial compositions comprising graphene-silver cation nanocomposites and uses for same as a broad-spectrum antimicrobial agent, and uses for same for treating microbial infections, including infections by antimicrobial resistant and/or multidrug resistant pathogens.